Docetaxel enhances the cytotoxic effects of imatinib on Philadelphia positive human chronic myeloid leukemia cells

ISSN： 1024-5332

Source： Hematology, Vol.14, Iss.3, 2009-06, pp. : 139-144

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mechanisms of cellular resistance to imatinib in human chronic myeloid leukemia cells

By Baran Yusuf Ural Ali Ugur Gunduz Ufuk

Hematology, Vol. 12, Iss. 6, 2007-12 ,pp. : 497-503

Maney Publishing

Access to resources Recommend Favorite

Imatinib Mesylate in Chronic Myeloid Leukemia

Current Stem Cell Research & Therapy, Vol. 2, Iss. 3, 2007-09 ,pp. : 249-251

Bentham Science Publishers

Access to resources Recommend Favorite

Philadelphia-positive T-cell acute lymphoblastic leukemia with polymyositis, migratory polyarthritis and hypercalcemia following a chronic myeloid leukemia

By Lima M. Coutinho J. Bernardo L. dos Anjos Teixeira M. Casais C. Canelhas Á. Queirós M. Orfão A. Justiça B.

Annals of Hematology, Vol. 81, Iss. 3, 2002-03 ,pp. : 174-177

Springer Publishing Company

Access to resources Recommend Favorite

The roles of epigenetic modifications of proapoptotic BID and BIM genes in imatinib-resistant chronic myeloid leukemia cells

By Bozkurt S黵eyya

Hematology, Vol. 18, Iss. 4, 2013-07 ,pp. : 217-223

Maney Publishing

Access to resources Recommend Favorite

Myeloid/natural killer cell blast crisis representing an additional translocation, t(3;7)(q26;q21) in Philadelphia-positive chronic myelogenous leukemia

By Henzan Hideho

Annals of Hematology, Vol. 83, Iss. 12, 2004-12 ,pp. : 784-788

Springer Publishing Company

Access to resources Recommend Favorite